BioVie announced that it intends to offer to sell shares of its common stock in a best efforts public offering. All of the shares of common stock are to be sold by the company. ThinkEquity is acting as sole placement agent for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BIVI:
- BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024
- SHAREHOLDER ALERT: Potential Recovery for BioVie Inc. (BIVI) Investors
- Biovie Inc. Is Worried About This – Should You Be Worried Too?
- BioVie Faces Class Action Lawsuit Over Drug Trial Claims
- Largest borrow rate increases among liquid names